QEO
- 产品代码
- QEO
- 器械名称
- Light Attenuation Lenses For Migraine-Associated Light Sensitivity
- 管理类别
- 第 1 类(Class I)
- 21 CFR 条款
- 21 CFR 882.5811
- FDA 专业组
- Neurology
- 上市路径
- 豁免 510(k)(仍须遵守通用控制与注册列名)
- 该代码近三年的 510(k)
- 1 件
FDA 分类定义
Light attenuation lenses for migraine-associated light sensitivity are devices that limit light incidence of specific wavelengths to the eyes and are intended to decrease the impact of light sensitivity in patients diagnosed with migraine. The lenses can be mounted on a spectacle frame, clips, or other apertures used to hold lenses. The device is intended to be adjunctive to other therapies for migraine-associated light sensitivity. Sunglasses (nonprescription) and prescription spectacle lenses are separately classified under § 886.5850 and § 886.5844, respectively.
该代码近三年的 510(k)(1 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| DEN250026 | 2026-08-21 | Matap Ii, LLC | Avulux | — |
FDA 官方分类页: QEO
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。